Stockholders’ Equity |
12 Months Ended |
|---|---|
Jun. 30, 2026 | |
| Equity [Abstract] | |
| Stockholders’ Equity | Note 13 – Stockholders’ Equity
Reverse Stock Split
On September 9, 2024, the Company’s stockholders approved an amendment to the Company’s articles of incorporation to effectuate a 1-for-2 reverse split of the Company’s common stock. The amendment to the Company’s articles of incorporation was filed with the Nevada Secretary of State on September 9, 2024. The consolidated financial statements, and all share and per share information contained herein, have been retroactively adjusted to reflect the reverse stock split.
As of June 30, 2026 and June 30, 2025, the Company had 110,000,000 shares of authorized capital, par value $, of which shares are designated as common stock, and shares are designated as preferred stock.
Equity Transactions
During the fiscal year ended June 30, 2026, stock options were exercised at $ per share of common stock.
During the fiscal year ended June 30, 2026, stock options were exercised at $ per share of common stock.
During the fiscal year ended June 30, 2026, the Company issued shares of common stock upon receipt of notice of the cashless exercise of a total of 143,750 warrants.
In August 2024, stock options were exercised at $ per share of common stock.
On September 27, 2024, the Company completed its initial public offering of shares of common stock, priced at $ per share. Concurrently, the Company issued shares as true up shares as a result of the 1-for-2 reverse split. In conjunction with the offering, the Company granted stock purchase warrants to purchase an aggregate of 143,750 shares of its common stock at an exercise price of $4.60 per share to underwriters.
During the three months ended December 31, 2024, in connection with the initial public offering, the Company issued common shares in respect to the underwriters’ option to purchase up to an additional shares of common stock to cover over-allotments.
On December 18, 2024, the Company issued common shares pursuant to the terms of the APA.
A total of stock options were exercised during the year ended June 30, 2025 at $ per share.
As of June 30, 2026 and June 30, 2025 the Company had and shares of common stock outstanding, respectively, and shares of preferred stock issued and outstanding.
|